DV
Dividend Vision

SNDX — Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc. (SNDX)

Total return is 65.2% over the past 10.4 years, 295.7 points behind SPY at 360.9%. Its deepest 1-year drawdown was 32.6%.

This equity fund focuses on the healthcare sector, specifically tracking Syndax Pharmaceuticals, Inc. as its underlying holding. The fund does not currently distribute dividends to shareholders and carries no publicly available expense ratio information. This security appeals primarily to growth-oriented investors seeking exposure to pharmaceutical companies rather than those pursuing current income generation.

SNDX key facts

Asset type
Stock
Asset class
Equity
Inception date
03/03/2016
Distribution frequency
None
Last close
$19.84
Market cap
$1,771,654,272
Average volume
1251152.0
Beta
0.373
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.51